Habitual consumption of soy protein and isoflavones and risk of metabolic syndrome in adults ≥ 40 years old: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort)
- 74 Downloads
Although considerable attention has been paid to the potential benefits of soy protein and isoflavones for preventing metabolic syndrome (MetS) and its components, findings linking habitual consumption of these factors to MetS are limited. This study aimed to evaluate the association of MetS incidence with habitual intake of soy protein/isoflavones among Korean men and women aged ≥ 40 years old who did not have MetS at baseline (n = 5509; 2204 men and 3305 women).
Dietary intake of soy protein/isoflavones at baseline and average consumption during follow-up were used.
A significant inverse association between dietary intake and incidence of MetS was found in women (incidence rate ratios, IRR = 0.60, 95% CI = 0.46–0.78, P for trend = 0.0094 for the highest quintile of average soy protein intake compared with the lowest quintile; IRR = 0.57, 95% CI = 0.44–0.74, P for trend = 0.0048 for the highest quintile of average isoflavones intake compared with the lowest quintile). A tendency towards an inverse association was also found in men, although it was not significant for the highest quintile (IRR = 0.80, 95% CI = 0.58–1.11, P for trend = 0.9759, comparing the lowest to the highest quintile of average soy protein intake; IRR = 0.73, 95% CI = 0.53–1.01, P for trend = 0.8956, comparing the lowest to the highest quintile of average isoflavones intake). In terms of individual abnormalities, a significant inverse association was found between soy protein and isoflavones and the incidence of low–high-density lipoprotein cholesterol in both men and women. Abdominal obesity and elevated blood pressure were inversely related to soy protein/isoflavones only in women, and an inverse association of elevated triglyceride appeared only in men.
Our findings suggest that habitual intake of soy protein and isoflavones is inversely associated with the risk of MetS and its components. There is likely to be a reverse J-shaped association of average intake with MetS.
KeywordsSoy protein Isoflavones Metabolic syndrome Prospective Korea
Body mass index
Coronary heart disease
Diet quality index-international
Fasting blood glucose
General linear model
High-density lipoprotein cholesterol
Incidence rate ratio
Korean Genome and Epidemiology Study
Multi-rural Communities Cohort
This work was supported by a Research Program funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00) and by a National Research Foundation of Korea grant funded by the Korean government (Ministry of Science, ICT & Future Planning), (no. 2016R1A2B2011352).
HWW contributed to the data analysis and wrote the manuscript. YHL, DHS, MHS, and BYC were involved in data collection and management. MKK designed the study and supervised all the aspects of its implementation. All the authors helped to conceptualize the study, interpret the findings, and review drafts of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Institutional Review Board of Hanyang University, Chonnam University, and Keimyung University) and with the Helsinki Declaration of 1964, as revised in 2000. Informed consent was obtained from all subjects for being included in the study.
- 9.Ramdath DD, Padhi EM, Sarfaraz S, Renwick S, Duncan AM (2017) Beyond the cholesterol-lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease. Nutrients. https://doi.org/10.3390/nu9040324 CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese Populations The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 116(22):2553–2562CrossRefGoogle Scholar
- 25.Bhagwat S, Haytowitz DB, Holden JM (2008) USDA database for the isoflavone content of selected foods, release 2.0, vol 15. US Department of Agriculture, MarylandGoogle Scholar
- 26.The Korean Nutrition Society (2009) Food values. The Korean Nutrition Society, SeoulGoogle Scholar
- 31.Shin B-R, Choi Y-K, Kim H-N, Song S-W (2016) High dietary calcium intake and a lack of dairy consumption are associated with metabolic syndrome in obese males: the Korean National Health and Nutrition Examination Survey 2010 to 2012. Nutr Res 36(6):518–525. https://doi.org/10.1016/j.nutres.2016.01.002 CrossRefPubMedGoogle Scholar
- 36.MacMahon B, Pugh TF (1970) Epidemiology: principles and methods, principles and methods. Little, Brown & Co, BostonGoogle Scholar
- 37.Ryu C, Hong S (2015) R visualication, 1st edn. Insignt, South KoreaGoogle Scholar
- 40.Food and Agriculture Organization of the United Nations (FAO). Food balance sheets. Available at http://faostat3.fao.org/download/FB/FBS/E. Accessed Aug 2016
- 41.Messina M, Messina V, Setchell KD (1994) The simple soybean and your health. Avery Pub. Group, New YorkGoogle Scholar
- 42.Canada H (2012) Summary of Health Canada’s Assessment of a health claim about barley products and blood cholesterol lowering. Health Canada Ottawa, OttawaGoogle Scholar
- 43.Stein K (2000) FDA approves health claim labeling for foods containing soy protein. J Acad Nutr Diet 100(3):292Google Scholar
- 44.EFSA Panel on Dietetic Products N, Allergies (2010) Scientific opinion on the substantiation of a health claim related to soy protein and reduction of blood cholesterol concentrations pursuant to Article 14 of the Regulation (EC) No 1924/2006. EFSA J 8(7):14Google Scholar
- 47.Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76(2):365–372. https://doi.org/10.1093/ajcn/76.2.365 CrossRefPubMedGoogle Scholar
- 50.Wong JM, Kendall CW, Marchie A, Liu Z, Vidgen E, Holmes C, Jackson CJ, Josse RG, Pencharz PB, Rao AV, Vuksan V, Singer W, Jenkins DJ (2012) Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods. Am J Clin Nutr 95(3):564–571. https://doi.org/10.3945/ajcn.111.017418 CrossRefPubMedGoogle Scholar
- 51.Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Park JK, Kim SS, Kim Y (2012) Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr 7(4):567–574. https://doi.org/10.1007/s12263-012-0292-8 CrossRefPubMedPubMedCentralGoogle Scholar
- 57.Squadrito F, Altavilla D, Morabito N, Crisafulli A, D’Anna R, Corrado F, Ruggeri P, Campo GM, Calapai G, Caputi AP (2002) The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 163(2):339–347CrossRefGoogle Scholar
- 58.Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD (2005) S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81(5):1072–1079CrossRefGoogle Scholar
- 61.Nozue M, Shimazu T, Sasazuki S, Charvat H, Mori N, Mutoh M, Sawada N, Iwasaki M, Yamaji T, Inoue M, Kokubo Y, Yamagishi K, Iso H, Tsugane S (2017) Fermented soy product intake is inversely associated with the development of high blood pressure: the Japan Public Health Center-Based Prospective Study. J Nutr 147(9):1749–1756. https://doi.org/10.3945/jn.117.250282 CrossRefPubMedGoogle Scholar